Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Studies to Predict Treatment Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma

NCT07063758 is registered in ClinicalTrials.gov with National Taiwan University Clinical Trial Center as lead sponsor.

NCT NCT07063758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07063758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Studies to Predict Treatment Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma
Lead sponsor
National Taiwan University Clinical Trial Center
Phase
Observational
Overall status
Active, not recruiting
Start date
April 1, 2025
Completion date
December 31, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced urothelial carcinoma